Barrier disruption by coagulation FXIa
- 24 October 2024
- journal article
- editorial
- Published by American Society of Hematology in Blood
- Vol. 144 (17) , 1760-1762
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Coagulation factor XI regulates endothelial cell permeability and barrier function in vitro and in vivoBlood, 2024
- Targeting factor XI and factor XIa to prevent thrombosisBlood, 2024
- Substrates, Cofactors, and Cellular Targets of Coagulation Factor XIaSeminars in Thrombosis and Hemostasis, 2023
- An update on factor XII-driven vascular inflammationBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2022
- Pharmacological targeting of coagulation factor XI mitigates the development of experimental atherosclerosis in low‐density lipoprotein receptor‐deficient miceJournal of Thrombosis and Haemostasis, 2021
- Platelet-localized FXI promotes a vascular coagulation-inflammatory circuit in arterial hypertensionScience Translational Medicine, 2017
- Apolipoprotein E Receptor 2 Mediates Activated Protein C–Induced Endothelial Akt Activation and Endothelial Barrier StabilizationArteriosclerosis, Thrombosis, and Vascular Biology, 2016
- Tissue Factor Pathway Inhibitor Blocks Angiogenesis via Its Carboxyl TerminusArteriosclerosis, Thrombosis, and Vascular Biology, 2012
- Regulation of tissue factor–induced signaling by endogenous and recombinant tissue factor pathway inhibitor 1Blood, 2005
- Tissue Factor Pathway Inhibitor Inhibits Endothelial Cell Proliferation via Association with the Very Low Density Lipoprotein ReceptorJournal of Biological Chemistry, 2001